CTX — Captor Therapeutics SA Balance Sheet
0.000.00%
Last trade - 00:00
- PLN385.59m
- PLN313.67m
- PLN13.20m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12.3 | 10.7 | 118 | 90.9 | 75.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.88 | 1.75 | 11.7 | 9.68 | 12.6 |
Prepaid Expenses | |||||
Total Current Assets | 14.7 | 13.2 | 131 | 101 | 88.6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10.4 | 12.2 | 12.6 | 10.7 | 6.95 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 25.3 | 25.8 | 144 | 113 | 97.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15.2 | 20 | 16.4 | 13.4 | 26.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 21 | 26.8 | 19.3 | 16.7 | 28.1 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 4.28 | -1 | 124 | 96.3 | 69.2 |
Total Liabilities & Shareholders' Equity | 25.3 | 25.8 | 144 | 113 | 97.3 |
Total Common Shares Outstanding |